Atossa Therapeutics
ATOS
#10640
Rank
โ‚น2.52 B
Marketcap
โ‚น252.74
Share price
3.94%
Change (1 day)
280.80%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚น3.38 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.33 Billion a decrease over its 2024 earnings that were of -โ‚น2.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.38 Billion1.31%
2025 -โ‚น3.33 Billion36.33%
2024 -โ‚น2.45 Billion-15.25%
2023 -โ‚น2.89 Billion11.62%
2022 -โ‚น2.59 Billion30.84%
2021 -โ‚น1.98 Billion15.58%
2020 -โ‚น1.71 Billion3.41%
2019 -โ‚น1.66 Billion51.16%
2018 -โ‚น1.1 Billion40.41%
2017 -โ‚น0.78 Billion27.54%
2016 -โ‚น0.61 Billion-47.49%
2015 -โ‚น1.17 Billion-17.25%
2014 -โ‚น1.41 Billion35.91%
2013 -โ‚น1.04 Billion112.3%
2012 -โ‚น0.49 Billion46.53%
2011 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.487 T-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น131.73 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น131.65 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.99 B-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.53 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.76 Billion-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA